Australian Clinical Labs Limited (ACL.AX)
AUD 3.49
(-3.32%)
AUD 3.49
(-3.32%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 56.9 Million AUD | 9.75% |
| 2023 | 51.85 Million AUD | -79.76% |
| 2022 | 256.23 Million AUD | 162.56% |
| 2021 | 97.59 Million AUD | 528.33% |
| 2020 | 15.53 Million AUD | 304.96% |
| 2019 | -7.57 Million AUD | -28.25% |
| 2018 | -5.9 Million AUD | 71.27% |
| 2017 | -20.56 Million AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 18.82 Million AUD | 60.72% |
| 2024 FY | 56.9 Million AUD | 9.75% |
| 2024 Q3 | 68.04 Million AUD | 261.43% |
| 2024 Q1 | 11.71 Million AUD | -47.16% |
| 2024 Q4 | 68.04 Million AUD | 0.0% |
| 2023 Q4 | 22.16 Million AUD | 51.59% |
| 2023 FY | 51.85 Million AUD | -79.76% |
| 2023 Q3 | 14.62 Million AUD | -57.94% |
| 2023 Q1 | 17.38 Million AUD | -79.04% |
| 2023 Q2 | 34.76 Million AUD | 100.0% |
| 2022 Q2 | 191.03 Million AUD | 98.6% |
| 2022 Q1 | 96.19 Million AUD | 39.54% |
| 2022 FY | 256.23 Million AUD | 162.56% |
| 2022 Q4 | 82.94 Million AUD | 103.3% |
| 2022 Q3 | 40.79 Million AUD | -78.64% |
| 2021 FY | 97.59 Million AUD | 528.33% |
| 2021 Q3 | 34.46 Million AUD | -41.65% |
| 2021 Q2 | 59.06 Million AUD | 100.0% |
| 2021 Q4 | 68.93 Million AUD | 100.0% |
| 2021 Q1 | 29.53 Million AUD | 123.43% |
| 2020 Q2 | 4.18 Million AUD | 30.84% |
| 2020 FY | 15.53 Million AUD | 304.96% |
| 2020 Q4 | 13.21 Million AUD | 119.08% |
| 2020 Q3 | 6.03 Million AUD | 44.1% |
| 2020 Q1 | 3.2 Million AUD | 0.0% |
| 2019 FY | -7.57 Million AUD | -28.25% |
| 2018 FY | -5.9 Million AUD | 71.27% |
| 2017 FY | -20.56 Million AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| BCAL Diagnostics Limited | -5.44 Million AUD | 1144.668% |
| Genetic Signatures Limited | -22.33 Million AUD | 354.802% |
| Genetic Technologies Limited | -6.53 Million AUD | 970.485% |
| Healius Limited | 39.7 Million AUD | -43.338% |
| Imagion Biosystems Limited | -15.81 Million AUD | 459.833% |
| Integral Diagnostics Limited | 5.36 Million AUD | -960.276% |
| INOVIQ Ltd | -9.51 Million AUD | 698.337% |
| Microba Life Sciences Limited | -26.84 Million AUD | 311.993% |
| Monash IVF Group Limited | -5.34 Million AUD | 1164.839% |
| Rhythm Biosciences Limited | -6.7 Million AUD | 948.412% |
| Sonic Healthcare Limited | 816.45 Million AUD | 93.03% |